Teva Pharmaceutical Industries Limited
TEVJF
$26.00
$7.5040.54%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.28% | 7.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.28% | 7.32% | |||
| Cost of Revenue | 4.92% | 2.98% | |||
| Gross Profit | 9.61% | 11.99% | |||
| SG&A Expenses | 1.46% | 4.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 80.00% | 150.00% | |||
| Total Operating Expenses | 4.02% | 3.14% | |||
| Operating Income | 19.24% | 26.09% | |||
| Income Before Tax | 217.65% | -30.61% | |||
| Income Tax Expenses | 374.36% | -205.41% | |||
| Earnings from Continuing Operations | 53.90% | 28.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 53.55% | 31.78% | |||
| EBIT | 19.24% | 26.09% | |||
| EBITDA | 14.85% | 20.15% | |||
| EPS Basic | 53.52% | 30.80% | |||
| Normalized Basic EPS | 29.14% | 35.08% | |||
| EPS Diluted | 54.17% | 33.33% | |||
| Normalized Diluted EPS | 28.84% | 35.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.79% | |||
| Average Diluted Shares Outstanding | 0.26% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||